NQO1/p65/CXCL12 Axis-Recruited Tregs Mediate Resistance to Anti-PD-1 Plus Lenvatinib Therapy in PIVKA-II-Positive Hepatocellular Carcinoma
NQO1/p65/CXCL12轴募集的调节性T细胞介导PIVKA-II阳性肝细胞癌对PD-1抑制剂联合乐伐替尼治疗的耐药性
期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202511152
Gao, Biao; Wang, Yafei; Sun, Zhuoya; Tang, Haowen; Cao, Yinbiao; Jiang, Hao; Zhang, Wenwen; Xu, Yinzhe; Hu, Bingyang; Liu, Zhe; Mao, Guankun; Li, Xuerui; Li, Junfeng; Wan, Tao; Liu, Bing; Zhao, Xiao; Jiao, Shunchang; Li, Chonghui; Lu, Shichun
CXCL12
NQO1
肿瘤
T细胞
肿瘤免疫
CXCL1
T细胞
细胞生物学
PD-1
免疫/内分泌